BrunoBastosMD

Oncology • Miami, FL

Genitourinary Oncology

Staff

Request Appointment

Overview of Dr. Bastos

Dr. Bruno Bastos is an oncologist in Miami, FL and is affiliated with Mount Sinai Medical Center. He received his medical degree from Federal University of Bahia Faculty of Medicine and has been in practice 16 years. He is one of 17 doctors at Mount Sinai Medical Center who specialize in Oncology. He has more than 10 publications and over 200 citings.

Office
Mount Sinai Medical Center
4300 Alton Rd
Miami, FL 33140
Book by Phone+1(786) 244-8559

Education & Training

Harvard Medical SchoolFellowship, Development Therapeutics, 2008 - 2009
Jackson Health System2005 - 2008
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2002 - 2005
Federal University of Bahia Faculty of MedicineClass of 2001

Certifications & Licensure

FL State Medical License 2009 - 2025
MA State Medical License 2008 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
No longer available
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
Active, not recruiting
Phase 3
A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors Start of enrollment: 2017 Dec 06
Active, not recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

57 citations
Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of ENMD-2076, a Novel Angiogenic and Aurora Kinase Inhibitor, in Patients with Advanced Solid Tumors
Jennifer R. Diamond, Bruno R. Bastos, Ryan J. Hansen, Daniel L. Gustafson, S. Gail Eckhardt
Clinical Cancer Research. 2011-02-15
5 citations
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies.
Yazmin Odia, Ludimila Cavalcante, Howard Safran, Steven Francis Powell, Pamela N Munster
Neuro-Oncology Advances. 2022-02-07
25 citations
Phase I Studies of CBP501, a G2 Checkpoint Abrogator, as Monotherapy and in Combination with Cisplatin in Patients with Advanced Solid Tumors
Geoffrey I. Shapiro, Raoul Tibes, Michael S. Gordon, Bryan Y. Wong, Joseph Paul Eder
Clinical Cancer Research. 2011-05-15

Press Mentions

Using Your Immune System to Fight Cancer Is Showing Significant PromiseMay 26th, 2017
Cleveland Clinic Cancer DoctorNovember 13th, 2016

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

External Links

ABIMhttps://www.abim.org/verify-physician.aspx?type=id&id=259861